Nitromifene citrate

CAS: 5863-35-4

Ref. 3D-FAA86335

Product Information

• Name: Nitromifene citrate
• Synonyms: 1-(2-(p-(alpha-(p-Methoxyphenyl)-beta-nitrostyryl)phenoxy)ethyl) pyrrolidine monocitrate, 1-(2-(p-(alpha-(p-Methoxyphenyl)-beta-nitrostyryl)phenoxy)ethyl)pyrrolidine citrate (1:1), 1-[2-(p-[a-(p-Methoxyphenyl)-β-nitrostyryl]-phenoxy)ethyl]pyrrolidine monocitrate, 1-[2-[4-[2-(4-Methoxyphenyl)-1-nitro-2-phenylethenyl]phenoxy]ethyl]pyrrolidine monocitrate, 1-[2-[p-[α-(p-Methoxyphenyl)-β-nitrostyryl]phenoxy]ethyl]pyrrollidine monocitrate, Ai3-52826, CI-628 citrate, Ci-628, Cn-55945-27, Nitromifene citrate [USAN], Nsc 110407, Parke davis CI-628, Pyrrolidine, 1-(2-(4-(1-(4-methoxyphenyl)-2-nitro-2-phenylethenyl)phenoxy)ethyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Pyrrolidine, 1-(2-(p-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)phenoxy)ethyl)-, citrate (1:1) (8CI), Pyrrolidine, 1-[2-[p-[α-(p-methoxyphenyl)-β-nitrostyryl]phenoxy]ethyl]-, citrate, Pyrrolidine, 1-[2-[p-[α-(p-methoxyphenyl)-β-nitrostyryl]phenoxy]ethyl]-, citrate (1:1), Unii-Tn5Uq266Ra
• CAS: 5863-35-4

Description

Nitromifene citrate is a nonsteroidal drug that inhibits the enzyme fatty acid synthase, thereby preventing the production of prostaglandins. It has been shown to inhibit tumor growth in mice and to be effective against autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Nitromifene citrate also binds to neurokinin-1 receptor and inhibits tissue culture granulosa cells. This drug has been shown to have clinical significance in the treatment of breast cancer. Nitromifene citrate is metabolized by the liver and is taken up into the brain where it can affect brain functions, such as emotional behavior or memory. Nitromifene citrate is synthesized by cultured cells in vitro and has been used for research purposes in vivo.

• Brand: Biosynth

Chemical properties

• Molecular weight: 636.6 g/mol
• Formula: C₃₃H₃₆N₂O₁₁
• Purity: Min. 95%